The Hidden Downside of GLP-ls: Triggering Disordered Eating
© 2026 Vannoni
We have written before on this site about the genuine cardiovascular benefits of GLP-1 medications. The SELECT trial data showing 20 percent fewer heart attacks and strokes are real and important, and I help Dr. Meyer co-manage these drugs for the right patients in this practice often. This piece is about a different side of the story, one that is beginning to surface in medical journals, in Wall Street Journal reporting, and in the offices of eating disorder specialists across the country.
Join Our Concierge Membership Program
For a small but meaningful group of patients, GLP-1 medications appear to be triggering, unmasking, or worsening disordered eating. As a dietitian/ nutritionist, this concerns me for two reasons. First, patients deserve honest information about the medications I recommend. Second, the ultimate cardiac consequences of severe restrictive eating are among the most serious complications we see in clinic. And, Dr. Meyer understands that the heart pays a heavy price when the body is starved.
Here is what patients and families should know.
What Do GLP-1 Drugs Actually Do?
GLP-1 receptor agonists mimic a hormone your gut releases after meals. They slow gastric emptying, help regulate blood sugar, and, importantly, act on appetite centers in the brain to reduce hunger and quiet what many patients describe as "food noise," the constant background chatter about what to eat next.
For patients with type 2 diabetes, obesity, or established cardiovascular disease, these effects can be life-changing. The FDA has approved these medications for those specific conditions, and the evidence supporting their use in those populations is strong.
The trouble starts at the edges of appropriate use.
~ Don’t Wait To Hear About The Newest Study - Be At The Center of State-of-the-Art Healthcare ~
Join Madison Avenue Concierge Medicine, Book a Consultation with Dr. Meyer
What Pattern Is Emerging in the Literature?
A Wall Street Journal investigation published in 2025 documented a growing number of cases in which GLP-1 medications appeared to trigger or worsen disordered eating patterns, including anorexia nervosa. Patients described losing interest in food entirely, becoming afraid of eating, and finding that the medication's appetite-suppressing effects reinforced restrictive habits they had struggled with in the past.
A striking case report published in BJPsych Open in December 2025 detailed an adolescent girl prescribed semaglutide by her primary care doctor for mild weight gain. Over six months she lost a significant portion of her body weight and was ultimately hospitalized with a dangerously slow heart rate and fluid around her heart, both classic cardiac complications of severe malnutrition. She was diagnosed with atypical anorexia nervosa, a form of the illness that can be missed because the patient's weight may still appear to fall in a normal range.
The National Association of Anorexia Nervosa and Associated Disorders, one of the country's leading eating disorder nonprofits, has published detailed guidance on this exact issue. Their clinical experts note that rapid appetite suppression and rapid weight loss, whether from a medication or any other cause, can destabilize recent recovery, trigger relapse, or unmask an eating disorder that had been dormant. Poison control call data cited by ANAD also suggests that calls related to GLP-1 overdose have tripled in recent years.
None of this means GLP-1 medications are dangerous when used correctly in the right patient. It means the population using them has expanded rapidly, often through telehealth and off-label prescribing pathways, and the safety net has not kept up.
Get The Meyer Nutrition Plan
Why Is This a Cardiology Issue?
The medical community sometimes talks about eating disorders as if they were purely a mental health condition. They are not. Anorexia nervosa has one of the highest mortality rates of any psychiatric illness, and cardiac complications are a major reason why.
When the body is systematically underfed, the heart muscle itself shrinks. Cardiac chambers become smaller. The resting heart rate drops, sometimes into ranges that would be dangerous in anyone else. Blood pressure falls. Electrical rhythm disturbances become more common. Fluid can accumulate around the heart. Electrolyte imbalances, particularly low potassium and magnesium, can trigger dangerous arrhythmias. These are not rare complications. They are what we look for when a patient with an eating disorder ends up in the hospital.
Importantly, all of this can happen even when a patient's weight looks fine on the outside. What matters is the rate and amount of weight lost, not whether the number on the scale is above or below any given threshold.
Who Is at Higher Risk?
Not everyone taking a GLP-1 is at risk of developing disordered eating. Most patients tolerate the medications well and use them as intended. But there are patterns that raise my concern, and I bring them up openly with patients in clinic.
Anyone with a personal history of anorexia, bulimia, binge eating disorder, or subclinical disordered eating should have a careful conversation with their doctor before starting one of these medications. So should anyone with a family history of eating disorders, a history of severe body image distress, or a pattern of yo-yo dieting and preoccupation with food.
Adolescents are a particular concern. The evidence base for GLP-1 use in this age group is thin, the risk of triggering an eating disorder is higher, and the long-term consequences of rapid weight loss during adolescent development are not fully understood.
I also worry about anyone obtaining these medications outside a supervised medical relationship, whether through unregulated online sources, compounding pharmacies without proper oversight, or telehealth services that skip the detailed screening a good primary care or specialty visit would include.
Which Warning Signs Are Worth Taking Seriously?
If you or someone you love is taking a GLP-1 medication, there are patterns worth paying attention to. Losing weight much faster than expected. Skipping meals routinely because there is simply no appetite. Feeling anxious or distressed at the thought of eating. Weighing yourself many times a day. Withdrawing from meals with family or friends. New rules about which foods are acceptable and which are not. A sense of pride or fear tied to the number on the scale.
Physical warning signs that call for prompt medical attention include a resting heart rate that keeps dropping, feeling faint on standing, cold intolerance, hair thinning, missed menstrual periods, and any chest pain or palpitations.
These do not automatically mean an eating disorder is developing, but they are worth raising with your doctor rather than waiting. And ultimately, it’s important to understand that these disorders can occur in people without preexisting body dysmorphia. However, people with a history of these disorders are likely more vulnerable to a relapse and should be seeing an eating-disorders specialist, as well as a dietitian who has training in and experience with eating disorders and body dysmorphia.
What to Do?
If you are taking a GLP-1 medication and something feels off, please talk with your prescribing physician. If you have a history of an eating disorder, whether current or past, please make sure that history is on the table in every conversation about weight loss medication. Bring in a therapist, dietitian, or eating disorder specialist as needed. Recovery from an eating disorder is delicate work, and it deserves a team.
If you or someone you love is struggling with an eating disorder, help is available. The National Alliance for Eating Disorders operates a confidential helpline staffed by licensed clinicians at 1-866-662-1235 and offers online referrals and support at allianceforeatingdisorders.com. The National Association of Anorexia Nervosa and Associated Disorders also runs a free helpline at 1-888-375-7767.
The Meyer Nutrition Plan combines a fully holistic approach to weight loss and wellbeing with highly personalized elite, concierge care.
Created by renowned New York cardiologist and internist Mark Meyer, MD, FACP, FACC,
our nutrition includes the most comprehensive health screening and management in Manhattan.
Book Appointment
GLP-1 medications are a genuine advance in cardiovascular and metabolic medicine. They are not villains, and this piece is not a warning against using them. What it is, is an honest acknowledgment that a class of drugs powerful enough to reshape appetite is also powerful enough to reshape a person's relationship with food, sometimes in ways that hurt them badly. Patients with a history of disordered eating, adolescents, and anyone starting these medications outside of a careful, monitored medical relationship deserve extra caution. The heart, in particular, cannot afford the fallout of a missed eating disorder.
As I mentioned, along with their healthcare provider, I also believe all patients using these medications should see a dietitian, too. This helps mitigate and monitor for known risks and helps optimize health, nutrition, and eating habits while on the medication. Often, people who eat less are not eating optimally or enough.
If you are considering one of these medications, or if you are already on one and worried about how it is affecting your relationship with food, come talk to us. That is exactly the kind of conversation a good cardiology visit should include.
